Allstocks.com's Bulletin Board Post New Topic  New Poll  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » BMSN

 - UBBFriend: Email this page to someone!    
Author Topic: BMSN
chartinator
New Member


Rate Member
Icon 1 posted      Profile for chartinator     Send New Private Message       Edit/Delete Post   Reply With Quote 
Biomatrix Scientific has a very unique niche. They recently received FDA approval for the storage of stem cells now that the new law has been passed. The CEO has already signed one contract recently and more details on it are going to be released shortly. The contracts will soon be rolling in. Fantastic niche and buying opportunity here. A buddy just drove up the coast and toured the facility and took pictures. I am very excited about this one and think we see it over $1 and trading between $1 and $1.45 inside of 3 to 4 weeks. Here is the most recent news:

Thu, Apr 03, 2008

9:18 AM Bio-Matrix Scientific Group, Inc. Signs Letter of Intent with VIBRAGENE for DNA / Genetic Testing - Business Wire

Tue, Apr 01, 2008

9:59 AM Bio-Matrix Scientific Group, Inc. Announces It Will Open Two DNA-Genetic Testing Labs - Business Wire

Thu, Mar 27, 2008

4:28 PM Bio-Matrix Scientific Group to Open Its Facility for Public Tours March 31, 2008 Through April 3, 2008 - Business Wire

Posts: 3 | Registered: Apr 2008  |  IP: Logged | Report this post to a Moderator
chartinator
New Member


Rate Member
Icon 1 posted      Profile for chartinator     Send New Private Message       Edit/Delete Post   Reply With Quote 
Bio-Matrix Scientific Group, Inc. Signs Letter of Intent with VIBRAGENE for DNA / Genetic Testing
Bio-Matrix Scientific Group Inc. (OTCBB:BMSN), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced today that it has entered into a Letter of Intent with VIBRAGENE, an anti-aging and genetic analysis company.

Pursuant to the Letter of Intent, it is proposed that Bio-Matrix Scientific Group, Inc. will perform human DNA genetic testing for biomarkers that may play important roles in disease development. VIBRAGENE anticipates sending 100,000 specimens to Bio-Matrix for testing during the next 12 months.

Additionally, Bio-Matrix will supply DNA testing kits to VIBRAGENE for the collection of DNA specimens.

Completion of the proposed agreement is subject to a number of conditions, including but not limited to, the establishment of pricing acceptable to the parties.

With recent advances in sequencing of the human genome, personalized medicine will become increasingly important in the treatment of diseases. The addition of DNA testing capability at the company’s Facility complements Bio-Matrix’ business lines of processing and storing stem cells for future medical uses.

Bio-Matrix currently has two Class 100,000 DNA laboratories that will be utilized to reduce the risks of contamination during DNA amplification and testing. These laboratories, combined with our current cGMP/cGTP requirements as an FDA registered Facility for stem cell operations, will assure clients of the highest standards in all technologies used.

About Bio-Matrix Scientific Group

Bio-Matrix Scientific Group Inc. (www.BMSN.us) is a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market. The company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation. Bio-Matrix’ new 15,000 sq. ft. state-of-the-art facility, located in the heart of San Diego’s biotechnology corridor, will house Bio-Matrix’ two secure Cryogenic Stem Cell Banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing laboratory, hematology, microbiology and flow cytometry laboratories.

DISCLAIMER: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


Bio-Matrix Scientific Group Inc.
Investor Relations
619-398-3517 ext. 301
info*BMSN.us

Posts: 3 | Registered: Apr 2008  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share